von Willebrand factor links primary hemostasis to innate immunity.
Clive DrakefordSonia ÁguilaFiona RocheKarsten HokampJudicael FazavanaMariana P CervantesAnnie M CurtisHeike C HawerkampSukhraj Pal Singh DhamiHugo Charles-MessanceEmer E HackettAlain ChionSoracha WardAzaz AhmadIngmar SchoenEamon BreenJoe KeaneRoss MurphyRoger J S PrestonJamie M O'SullivanFrederick J SheedyPadraic G FallonJames S O'DonnellPublished in: Nature communications (2022)
The plasma multimeric glycoprotein von Willebrand factor (VWF) plays a critical role in primary hemostasis by tethering platelets to exposed collagen at sites of vascular injury. Recent studies have identified additional biological roles for VWF, and in particular suggest that VWF may play an important role in regulating inflammatory responses. However, the molecular mechanisms through which VWF exerts its immuno-modulatory effects remain poorly understood. In this study, we report that VWF binding to macrophages triggers downstream MAP kinase signaling, NF-κB activation and production of pro-inflammatory cytokines and chemokines. In addition, VWF binding also drives macrophage M1 polarization and shifts macrophage metabolism towards glycolysis in a p38-dependent manner. Cumulatively, our findings define an important biological role for VWF in modulating macrophage function, and thereby establish a novel link between primary hemostasis and innate immunity.